FEFranziska A. V. Elsen

Franziska A. V. Elsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Franziska A. V. Elsen has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Stephan Axel Sieber

    Center for Functional Protein Assemblies (CPA) Department of Bioscience, TUM School of Natural Sciences Technical University of Munich (TUM) Garching Germany

    2 shared publications
  • Andrew Ji

    Research Service, Atlanta VA Medical Center

    1 shared publication
  • Carter U. Brzezinski

    Department of Chemistry, Emory University

    1 shared publication
  • Dietmar H. Pieper

    Helmholtz Centre for Infection Research, Microbial Interactions and Processes, Inhoffenstraße 7, 38124 Braunschweig, Germany

    1 shared publication
  • Dietrich Mostert

    Center for Functional Protein Assemblies, Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Ernst-Otto-Fischer-Straße 8, 85748 Garching, Germany

    1 shared publication
  • Dominik Schum

    TUM School of Natural Sciences, Department of Bioscience, Center for Functional Protein Assemblies (CPA), Chair of Organic Chemistry II, Technical University of Munich, Ernst-Otto-Fischer Strasse 8, Garching bei München, 85748, Germany

    1 shared publication

Latest Publications

  • Open Access

    Repurposing a drug to punish carbapenem-resistant Acinetobacter baumannii

    by Jennifer M. Colquhoun, Carter U. Brzezinski, Andrew Ji, Julianna Marotta, Franziska A. V. Elsen, Robert A. Bonomo, Kerrie L. May, Stephan A. Sieber, Marcin Grabowicz, William M. Wuest, et al.

    The OXA β-lactamases in Acinetobacter baumannii represent a primary mechanism for resistance to the carbapenems, a class of antibiotics that represent a last line for treatment. In a screen of an U.S. Food and Drug Administration (FDA)-approved drug library, we identified fendiline, a calcium channel blocker, had significantly more antimicrobial activity against OXA-23 expressing cells. Genetic and proteomic studies revealed that fendiline inhibited the essential lipoprotein trafficking pathway (Lol) in both A. baumannii (LolFD) and Escherichia coli (LolCDE). We demonstrate that OXA-23 is an outer membrane lipoprotein and its overexpression resulted in increased lethality in lolFD- depleted A. baumannii . Our results indicate that overexpression of the OXA-23 β-lactamase in A. baumannii stresses normal lipoprotein trafficking, which makes these cells more susceptible to fendiline. Overall, our data reveal a link between carbapenem resistance and the Lol pathway, which can be leveraged for new drug development.


  • Open Access

    Screening Privileged Alkyl Guanidinium Motifs under Host-Mimicking Conditions Reveals a Novel Antibiotic with an Unconventional Mode of Action

    by Dominik Schum, Franziska A. V. Elsen, Stuart Ruddell, Kenji Schorpp, Howard Junca, Mathias Müsken, Shu-Yu Chen, Michaela K. Fiedler, Thomas Pickl, Dietmar H. Pieper, et al.

    Screening large molecule libraries against pathogenic bacteria is often challenged by a low hit rate due to limited uptake, underrepresentation of antibiotic structural motifs, and assays that do not resemble the infection conditions. To address these limitations, we present a screen of a focused library of alkyl guanidinium compounds, a structural motif associated with antibiotic activity and enhanced uptake, under host-mimicking infection conditions against a panel of disease-associated bacteria. Several hit molecules were identified with activities against Gram-positive and Gram-negative bacteria, highlighting the fidelity of the general concept. We selected one compound (L15) for in-depth mode of action studies that exhibited bactericidal activity against methicillin-resistant Staphylococcus aureus USA300 with a minimum inhibitory concentration of 1.5 μM. Structure-activity relationship studies confirmed the necessity of the guanidinium motif for antibiotic activity. The mode of action was investigated using affinity-based protein profiling with an L15 probe and identified the signal peptidase IB (SpsB) as the most promising hit. Validation by activity assays, binding site identification, docking, and molecular dynamics simulations demonstrated SpsB activation by L15, a recently described mechanism leading to the dysregulation of protein secretion and cell death. Overall, this study highlights the need for unconventional screening strategies to identify novel antibiotics.


  • Open Access

    Synthesis and biological evaluation of vioprolide B and its dehydrobutyrine-glycine analogue

    by Noé Osorio Reineke, Franziska A. V. Elsen, Hanusch A. Grab, Dietrich Mostert, Stephan A. Sieber, Thorsten Bach

    Vioprolide B and an analogue, in which the ( E )-dehydrobutyrine was replaced by glycine, were synthesized and studied in biological assays which revealed cytotoxicity solely for vioprolide B, presumably by covalent binding to the target protein.